Wetenschappelijke publicaties van Erasme

Wetenschappelijke publicaties van Erasme

  • Hypoperfusion Intensity Ratio Predicts Successful Recanalization in M2 Middle Cerebral Artery Occlusion Stroke Treated with Thrombectomy.

  • Auteurs Salim HA, Kooshki A, Lakhani DA, Hoseinyazdi M, Faizy TD, Heit JJ, Liebeskind DS, Mei J, Wolman D, Albers GW, Sriwastwa A, Cho A, Guenego A, Dmytriw AA, Yedavalli VS
  • Revue AJNR Am J Neuroradiol
  • Date de publication 2026-02
Hypoperfusion Intensity Ratio Predicts Successful Recanalization in M2 Middle Cerebral Artery Occlusion Stroke Treated with Thrombectomy.
  • In vivo modeling of human γδ T cell ontogeny reveals terminal deoxynucleotidyl transferase as a key regulator of type 3 Vδ2 T cell development.

  • Auteurs La C, Detavernier A, Papadopoulou M, Sanchez Sanchez G, Martens V, Thomas S, Nguyen M, Acolty V, Melchior M, Venturoli D, de Toeuf B, Azouz A, Rezwani M, Tafesse Y, Verdebout I, Rongvaux A, Boehme L, Taghon T, Venken K, Elewaut D, Goriely S, Vermijlen D
  • Revue Cell Rep
  • Date de publication 2026-02
In vivo modeling of human γδ T cell ontogeny reveals terminal deoxynucleotidyl transferase as a key regulator of type 3 Vδ2 T cell development.
  • Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.

  • Auteurs Gendard M, Seksik P, Stefanescu C, Meyer A, Nachury M, Nancey S, Savoye G, Allez M, Laharie D, Serrero M, Franchimont D, Mathieu N, Fumery M, Vuitton L, Nahon S, Gilletta C, Rouillon C, Nuzzo A, Berre CL, Caron B, Buisson A, Amil M, Charkaoui M, Cadiot G, Caillo L, Simon M, Reenaers C, Hébuterne X, Plastaras L, Atanasiu C, Kwiatek S, Uzzan M, Pelletier AL, Benezech A, Vidon M, Goutorbe F, Geyl S, Cellier C, Montuclard C, Moussata D, Altwegg R, Amiot A
  • Revue Dig Liver Dis
  • Date de publication 2026-02
Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.
  • Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticus.

  • Auteurs Hanin A, Marois C, Guillemaud M, Chavez M, Cosme L, Hayatou Z, Besnard A, Goudard G, Masson V, Cousyn L, Cheval M, Denis JA, Alkouri R, Lamari F, Bisulli F, Eschbach K, Farias-Moeller R, Gaspard N, Gerard EE, Giovannini G, Gofton T, Gopaul MT, Kellogg M, Meletti S, Muccioli L, Pasini E, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Wong N, Bonnefont-Rousselot D, Demeret S, Hirsch LJ, Navarro V
  • Revue Epilepsia
  • Date de publication 2026-02
Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticus.
Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Decorative image of doctor and patient

Alle wetenschappelijke publicaties van het H.U.B.

Bekijk alle wetenschappelijke publicaties van het H.U.B.